Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CodaLytic - Codagenix

Next Previous
Drug Profile

CodaLytic - Codagenix

Alternative Names: CodaLytic™

Latest Information Update: 31 Oct 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Codagenix
  • Class Antineoplastics; Immunotherapies; Oncolytic viruses
  • Mechanism of Action Cell death stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Breast cancer

Most Recent Events

  • 18 Oct 2023 Codagenix terminates a phase I trial prior to enrolment in Breast Cancer (Metastatic disease, Inoperable/Unrespectable) in the USA (Intratumoural) due to funding decision by sponsor (NCT05600582)
  • 14 Apr 2023 Pharmacodynamics data from a preclinical study in Breast cancer presented at the 114th Annual Meeting of the American Association for Cancer Research,2023 (AACR-2023)
  • 06 Dec 2022 Pharmacodynamics data from a preclinical study in Breast cancer presented at the 45th Annual San Antonio Breast Cancer Symposium (SABCS-2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top